Patent 10143695 was granted and assigned to Mersana Therapeutics on December, 2018 by the United States Patent and Trademark Office.
The present disclosure relates generally to derivatives of pyrrolobenzodiazepines and antibody-drug conjugates thereof and to methods of using these conjugates as therapeutics and/or diagnostics.